These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26446417)

  • 61. Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.
    Li J; Deng Z; Wang Z; Wang D; Zhang L; Su Q; Lai Y; Li B; Luo Z; Chen X; Chen Y; Huang X; Ma J; Wang W; Bi J; Guan X
    Oncotarget; 2015 Apr; 6(10):8323-38. PubMed ID: 25831050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.
    Gao X; Cai Y; An R
    Int J Mol Med; 2018 Sep; 42(3):1229-1236. PubMed ID: 29845221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma.
    Yu Q; Wang J; Li T; Xu X; Guo X; Ding S; Zhu L; Zou G; Chen Y; Zhang X
    Biomed Res Int; 2021; 2021():2282916. PubMed ID: 34712728
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proliferation of poorly differentiated endometrial cancer cells through autocrine activation of FGF receptor and HES1 expression.
    Mori M; Mori T; Yamamoto A; Takagi S; Ueda M
    Hum Cell; 2019 Jul; 32(3):367-378. PubMed ID: 30963412
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cigarette smoke components induced the cell proliferation and epithelial to mesenchymal transition via production of reactive oxygen species in endometrial adenocarcinoma cells.
    Kim SM; Hwang KA; Choi DW; Choi KC
    Food Chem Toxicol; 2018 Nov; 121():657-665. PubMed ID: 30236600
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells.
    Lee KJ; Kim NH; Kim HS; Kim Y; Lee JJ; Kim JH; Cho HY; Jeong SY; Park ST
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241228
    [No Abstract]   [Full Text] [Related]  

  • 67. Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells.
    Tsubamoto H; Inoue K; Sakata K; Ueda T; Takeyama R; Shibahara H; Sonoda T
    Anticancer Res; 2017 Feb; 37(2):515-519. PubMed ID: 28179296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of BMI1 Gene on Regulating Apoptosis, Invasion, and Migration of HEC-1B Cells Induced by Ionizing Radiation.
    Chen L; Luo W; Ji P; Li Z; Yan Y; Zhou Q
    J Healthc Eng; 2022; 2022():7052066. PubMed ID: 35281533
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells.
    Duan X; Liu X; Cao Y; Li Y; Silayiding A; Zhang L; Wang J
    Clin Breast Cancer; 2021 Feb; 21(1):e1-e17. PubMed ID: 33168448
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-424 regulates epithelial-mesenchymal transition of endometrial carcinoma by directly targeting insulin-like growth factor 1 receptor.
    Shu S; Liu X; Xu M; Gao X; Fan J; Liu H; Li R
    J Cell Biochem; 2019 Feb; 120(2):2171-2179. PubMed ID: 30187960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
    Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
    Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR-652 Promotes Tumor Proliferation and Metastasis by Targeting
    Sun X; Dongol S; Qiu C; Xu Y; Sun C; Zhang Z; Yang X; Zhang Q; Kong B
    Mol Cancer Res; 2018 Dec; 16(12):1927-1939. PubMed ID: 30093563
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the ERK/MMP9 signaling pathway].
    Wu C; Cheng W
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
    Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
    Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
    [TBL] [Abstract][Full Text] [Related]  

  • 75. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance.
    Murakami A; Yakabe K; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Al-Mulla F; Sugino N
    Cancer Lett; 2012 Oct; 323(1):69-76. PubMed ID: 22542806
    [TBL] [Abstract][Full Text] [Related]  

  • 77. miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.
    Deng X; Hou C; Liang Z; Wang H; Zhu L; Xu H
    Dis Markers; 2017; 2017():2827435. PubMed ID: 28827892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.
    Dai Y; Xia W; Song T; Su X; Li J; Li S; Chen Y; Wang W; Ding H; Liu X; Li H; Zhao Q; Shao N
    Nucleic Acid Ther; 2013 Feb; 23(1):29-34. PubMed ID: 23205572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
    Kent CN; Guttilla Reed IK
    Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Anticancer Effects of Radachlorin-mediated Photodynamic Therapy in the Human Endometrial Adenocarcinoma Cell Line HEC-1-A.
    Kim SM; Rhee YH; Kim JS
    Anticancer Res; 2017 Nov; 37(11):6251-6258. PubMed ID: 29061808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.